Company Announcements

Invitrogen and PamGene will co-market Invitrogen’s Nuclear Hormone Receptor proteins and Lanthascreen assay technology with PamGene’s PamChip and PamStation Nuclear Hormone Receptor screening tools.

Clinical Data and Affymetrix entered into a marketing agreement for a new drug metabolism service.

Source BioScience will exclusively distribute Empire Genomics’ ACCUarray CGH genotyping technology in the UK.

In February, Affymetrix announced a restructuring plan, under which it will move the majority of its probe-array manufacturing from California to Singapore by the end of 2008.

In March, Roche NimbleGen announced it had expanded the terms of its license to a number of Affymetrix patents (see IBO 12/15/06) to include certain diagnostic rights for DNA copy number analysis and resequencing.

Agilent named Oxford Gene Technology a certified service provider in Europe.

Fred Hutchinson Cancer Research Center and South Korea–based NSB POSTECH will collaborate to develop antibody microarrays.

Affymetrix signed an agreement with Indian biotech Avesthagen, which will use Affymetrix microarrays for a genetic study of more than 60,000 Parsi individuals.

In March, Illumina appointed Mike Bouchard vice president of Finance. He was previously vice president of Finance and Accounting for Websense.

Product Introductions

In January, Affymetrix launched the Drug Metabolizing Enzymes and Transporters Early Access solution for access to all clinically relevant ADME markers in a single assay. It is available through the company’s Services Laboratory and Cogenics, a subsidiary of Clinical Data.

In March, Affymetrix introduced the Cytogenetic Solution, combining its high-density SNP Array 6.0 with a cytogenetics copy number assay and Intuitive Genotyping Console 2.1 software.

Agilent released GeneSpring GX 9.0, with guided workflows for Agilent, Affymetrix and Illumina microarrays.

BioDiscovery released Nexus Copy Number Professional 3.0.

SciGene introduced the Mai Tai Hybridization System for incubating four Agilent slide-microarrays at once.

Invitrogen released the NCode Human miRNA Microarray v3.

In March, Roche NimbleGen launched NimbleGen Sequence Capture technology, a sample preparation solution for targeted genome resequencing, as a service.

In April, Agilent introduced the Human miRNA Microarray v2.0, Mouse miRNA Microarray v1.0 and Rat miRNA Microarray v1.0

< | >